Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003765328 | SCV000260356 | likely benign | Familial adenomatous polyposis 1 | 2024-10-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000440805 | SCV000515738 | benign | not specified | 2015-04-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000569791 | SCV000667446 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000569791 | SCV000681462 | likely benign | Hereditary cancer-predisposing syndrome | 2016-08-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997609 | SCV004837403 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-11-20 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003765328 | SCV004933001 | benign | Familial adenomatous polyposis 1 | 2024-03-01 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |